Back to Search
FARRELL JOHNSON, MD
MD
Health Maintenance Organization
NPI: 1518062207Individual
Specialties, Licenses & Credentials
Health Maintenance OrganizationPrimary
Health Maintenance Organization
Code: 302R00000X
L4009(TX)
Research & Publications (20)
Abrogation of signal transducer and activator of transcription 3 reactivation after Src kinase inhibition results in synergistic antitumor effects.
PMID 17634553·Clin Cancer Res·2007
8-other
SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy.
PMID 18045060·Anticancer Agents Med Chem·2007
6-review
Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma.
PMID 16342249·Cancer·2006
3-trial
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
PMID 16203784·Clin Cancer Res·2005
8-other
A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
PMID 16199307·Int J Radiat Oncol Biol Phys·2005
3-trial
Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
PMID 15887238·J Cell Physiol·2005
8-other
Cyclooxygenase-2 induction and prostaglandin E2 accumulation in squamous cell carcinoma as a consequence of epidermal growth factor receptor activation by imatinib mesylate.
PMID 15844661·J Exp Ther Oncol·2004
8-other
A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status.
PMID 14983495·Cancer·2004
3-trial
Dose-dense therapy with a novel irinotecan regimen for small-cell lung cancer.
PMID 12886869·Oncology (Williston Park)·2003
3-trial
Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.
PMID 14596703·Clin Lung Cancer·2003
3-trial
Alterations in taste sensation: a case presentation of a patient with end-stage pancreatic cancer.
PMID 11318263·Cancer Nurs·2001
5-case
Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival.
PMID 19625608·Am J Physiol Cell Physiol·2009
8-other
Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms.
PMID 19564615·Proc Natl Acad Sci U S A·2009
7-preclinical
Bone metabolism in fetuses of pregnant women exposed to single and multiple courses of corticosteroids.
PMID 19546756·Obstet Gynecol·2009
4-observational
Meeting report: second international meeting on quadruplex DNA.
PMID 19555734·Biochimie·2009
7-preclinical
Maternal smoking and acute respiratory infection symptoms among young children in Nepal: multilevel analysis.
PMID 19563695·J Biosoc Sci·2009
8-other
The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis.
PMID 19632272·Neurotoxicology·2009
7-preclinical
Left heart decompression by atrial stenting during extracorporeal membrane oxygenation.
PMID 19569032·Int J Artif Organs·2009
5-case
Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation.
PMID 19602548·Clin Cancer Res·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12575 TOULOUSE ST
HOUSTON, TX 77015 - Phone
- (713) 218-8186
Quick Facts
- NPI
- 1518062207
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile